NCT03129230 is a NA clinical trial of free nonvascularized fibula autograft in Bone Diseases, sponsored by Yulin Orthopedics Hospital of Chinese and Western Medicine.

Who is sponsoring NCT03129230?

NCT03129230 is sponsored by Yulin Orthopedics Hospital of Chinese and Western Medicine.

What drugs are being tested in NCT03129230?

Interventions in NCT03129230: free nonvascularized fibula autograft.

What condition does NCT03129230 study?

NCT03129230 studies Bone Diseases.

Is NCT03129230 still recruiting?

NCT03129230 is currently completed. Last updated 27 November 2018.

Last reviewed 2018-11-27 · How we verify

NCT03129230

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Free Nonvascularized Fibula Autograft for Tumor-like Lesions in Femoral Neck Using in Pediatric Patients

Completed NA Last updated 27 November 2018

What this trial tests

NA trial testing free nonvascularized fibula autograft in Bone Diseases in 16 participants. Completed in 1 March 2017.

Timeline

1 August 2012

Primary endpoint
1 September 2016

1 March 2017

Quick facts

Lead sponsor	Yulin Orthopedics Hospital of Chinese and Western Medicine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	16
Start date	1 August 2012
Primary completion	1 September 2016
Estimated completion	1 March 2017
Sites	2 locations across China

Drugs / interventions tested

free nonvascularized fibula autograft

Conditions studied

Bone Diseases — all drugs for Bone Diseases →

Sponsor

Yulin Orthopedics Hospital of Chinese and Western Medicine

Who can join

Adults 7 to 13, any sex, with Bone Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was to evaluate the safety and efficacy of free nonvascularized fibula autograft in the treatment of the femoral neck tumor-like lesions before epiphyseal closure in pediatric patients, by presenting the clinic-radiological outcome and complications.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Treatment of tumor-like lesions in the femoral neck using free nonvascularized fibular autografts in pediatric patients before epiphyseal closure.
Luo S, Jiang T, Yang X, Yang Y, et al · · 2019 · cited 4× · PMID 30556444 · DOI 10.1177/0300060518813510

Verify or expand the search:

Other recruiting trials for Bone Diseases

Currently open trials in the same condition.

NCT06745791 — Clinical Validation of BoneMRI in the Spine · recruiting
NCT03571191 — Denosumab Treatment for Fibrous Dysplasia · Phase 2 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03129230 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yulin Orthopedics Hospital of Chinese and Western Medicine
Last refreshed: 27 November 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03129230.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing